Postdoctoral Fellow - Translational Breast Cancer Research
Posted: April 18, 2022
Job DescriptionA Postdoctoral position is available in the Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. This position reports to Dr. Xiaoping Wang.
The laboratory conducts basic and translational research to understand the aggressiveness of inflammatory breast cancer (IBC) and establish effective targeted therapies for patients with IBC. The research focuses on the mechanism underlying tumorigenesis and metastasis of IBC and the modulation of tumor microenvironment. Technologies include humanized/transgenic mouse modeling, immune profiling, single-cell RNA sequencing, multiplexed immunofluorescence staining, and in vitro and in vivo drug screening. The postdoctoral fellow will have the opportunity to work with clinical collaborators to learn how to translate the bench work into clinical trials. The postdoctoral fellow will also have the opportunity to work with the pharmaceutical companies to accelerate the translation of promising therapeutic drugs.
Applicants must have a recent Ph.D. degree with experience in molecular biology, cell biology, cancer biology, or related fields. We seek highly motivated and self-driven post-doctoral research fellow with strong research capabilities. We expect the postdoc candidate to join the lab in two months.
Xiaoping Wang, PhD
Department of Breast Medical Oncology
Section of Translational Breast Cancer Research
Morgan Welch Inflammatory Breast Cancer Research Program
It is the policy of The University of Texas MD Anderson Cancer Center to provide equal employment opportunity without regard to race, color, religion, age, national origin, sex, gender, sexual orientation, gender identity/expression, disability, protected veteran status, genetic information, or any other basis protected by institutional policy or by federal, state or local laws unless such distinction is required by law. http://www.mdanderson.org/about-us/legal-and-policy/legal-statements/eeo-affirmative-action.html